NEARLY 40 jobs could be lost from the GlaxoSmithKline site in Barnard Castle as part of a re-organisation within its Quality Assurance department.
But there will be no compulsory redundancies, GSK has confirmed and instead, it is hoped the job losses can be achieved through voluntary redundancy and natural turnover of staff and contractors.
Communications manager, Philip Brown, told the Mercury the factory was needing to streamline its Quality Assurance department, and staff have been offered the option of voluntary redundancy.
“There’s the potential reduction of 40 jobs,” he said. “This is a re-organisation project. We have a feel for the way things are going. We’ve been looking at streamlining this department and we saw opening up voluntary redundancy in this area as an opportunity to meet the needs of the business.”
However, should the 40 redundancies fail to be met voluntarily, then they will not be met compulsorily, stressed Mr Brown.
“There are up to 40 people, but this is not a hard and fast figure,” he said. “We’re making sure that whatever we do doesn’t compromise anyone. Obviously if people have got key skills, then clearly we’ll be looking to keep them employed in other parts of the factory.”